The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease

NCT00623324 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

INDUSTRY

Sponsor class

Conditions

Early Stage Parkinson's Disease

Interventions

DRUG: Aplindore
DRUG: Placebo

Sponsor

Ligand Pharmaceuticals